EUVIMEDEUVIMED entdecken
Open Access

CTC1-STN1-TEN1 controls DNA break repair pathway choice via DNA end resection blockade

Cody M Rogers iD, Hardeep Kaur iD, Michelle L Swift iD, Vivek B Raina iD, Shuo Zhou iD, Ajinkya S Kawale iD, Shahrez Syed iD, Korilynn G Kelly iD, Angela M Jasper iD, Sameer Salunkhe, Youngho Kwon iD, Jeffrey Wang iD und 20 weitere

Science · 2025

DOI: 10.1126/science.adt3034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, 2025. Verfasst von Cody M Rogers und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Structural Biology and Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San …. Hauptthemen laut MEDLINE: DNA Breaks, Double-Stranded, Telomere-Binding Proteins, DNA Repair, DNA End-Joining Repair. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antagonistic activities of the 53BP1 axis and the tumor suppressor BRCA1-BARD1 determine whether DNA double-strand breaks (DSBs) are repaired by end joining or homologous recombination. We show that the CTC1-STN1-TEN1 (CST) complex, a central 53BP1 axis component, suppresses DNA end resection by EXO1 and the BLM-DNA2 helicase-nuclease complex but acts by distinct mechanisms in restricting these entities. Whereas BRCA1-BARD1 alleviates the CST-imposed EXO1 blockade, it has little effect on BLM-DNA2 restriction. CST mutants impaired for DNA binding or BLM–EXO1 interaction exhibit a hyper-resection phenotype and render BRCA1-deficient cells resistant to poly(ADP–ribose) polymerase (PARP) inhibitors. Our findings mechanistically define the crucial role of CST in DNA DSB repair pathway choice and have implications for understanding cancer therapy resistance stemming from dysfunction of the 53BP1 axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Breaks, Double-StrandedTelomere-Binding ProteinsDNA RepairDNA End-Joining RepairHumansExodeoxyribonucleasesTumor Suppressor p53-Binding Protein 1RecQ HelicasesPoly(ADP-ribose) Polymerase InhibitorsBRCA1 ProteinDNA HelicasesUbiquitin-Protein LigasesDNA Repair EnzymesTumor Suppressor ProteinsHomologous RecombinationRecombinational DNA Repair

Substanzen

ExodeoxyribonucleasesTelomere-Binding ProteinsTumor Suppressor p53-Binding Protein 1EXO1 protein, humanTP53BP1 protein, humanRecQ HelicasesPoly(ADP-ribose) Polymerase InhibitorsBRCA1 ProteinCtc1 protein, humanBloom syndrome protein

Autor:innen und Institutionen

  • Department of Biochemistry and Structural Biology and Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Department of Biochemistry and Molecular Biophysics, Columbia University Irving Medical Center, New York, NY, USA.
  • Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Department of Neurosurgery, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

ORCID-Profile: Cody M Rogers, Hardeep Kaur, Michelle L Swift, Vivek B Raina, Shuo Zhou, Ajinkya S Kawale, Shahrez Syed, Korilynn G Kelly, Angela M Jasper, Youngho Kwon, Jeffrey Wang, Adam Sacks, Maria E Gaczynska, Pawel A Osmulski, Yashpal Rawal, Elizabeth V Wasmuth, Shaun K Olsen, Weixing Zhao, Robert Hromas, David S Libich, Alexander V Mazin, Eric C Greene, Dipanjan Chowdhury, Patrick Sung

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • NIEHS NIH HHS
  • NIA NIH HHS

Zitieren

APA

Rogers, C. M., Kaur, H., Swift, M. L., Raina, V. B., Zhou, S., Kawale, A. S., Syed, S., Kelly, K. G., Jasper, A. M., Salunkhe, S., Kwon, Y., Wang, J., Shabestari, A. B., Daley, J. M., Sacks, A., Gaczynska, M. E., Osmulski, P. A., Rawal, Y., Tomimatsu, N., …, & Sung, P. (2025). CTC1-STN1-TEN1 controls DNA break repair pathway choice via DNA end resection blockade. Science. https://doi.org/10.1126/science.adt3034

Vancouver

Rogers CM, Kaur H, Swift ML, Raina VB, Zhou S, Kawale AS, et al. CTC1-STN1-TEN1 controls DNA break repair pathway choice via DNA end resection blockade. Science. 2025. doi:10.1126/science.adt3034

BibTeX
@article{Rogers2025,
  author = {Rogers, Cody M and Kaur, Hardeep and Swift, Michelle L and Raina, Vivek B and Zhou, Shuo and Kawale, Ajinkya S and Syed, Shahrez and Kelly, Korilynn G and Jasper, Angela M and Salunkhe, Sameer and Kwon, Youngho and Wang, Jeffrey and Shabestari, Aida Badamchi and Daley, James M and Sacks, Adam and Gaczynska, Maria E and Osmulski, Pawel A and Rawal, Yashpal and Tomimatsu, Nozomi and Gayther, Simon A and Lawrenson, Kate and Burma, Sandeep and Wasmuth, Elizabeth V and Olsen, Shaun K and Zhao, Weixing and Hromas, Robert and Libich, David S and Mazin, Alexander V and Zhou, Daohong and Greene, Eric C and Chowdhury, Dipanjan and Sung, Patrick},
  title = {CTC1-STN1-TEN1 controls DNA break repair pathway choice via DNA end resection blockade},
  journal = {Science},
  year = {2025},
  doi = {10.1126/science.adt3034}
}
Kostenlos starten →